Evidence map›Paper›PMID 33602882›Full record

ArticleThe Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology2021

Centromere protein U enhances the progression of bladder cancer by promoting mitochondrial ribosomal protein s28 expression.

Bei-Bei Liu, Tao Ma, Wei Sun, Wu-Yue Gao, Jian-Min Liu, Li-Qiang Li, Wen-Yong Li, Sheng Wang, Yuan-Yuan Guo

Open access · diamondAbstract read
In one paragraph

Article in The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [Centromere protein U is highly expressed in colorectal cancer and associated with a poor long-term prognosis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Bei-Bei LiuDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
Tao MaDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
Wei SunDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
Wu-Yue GaoDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
Jian-Min LiuDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
Li-Qiang LiDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
Wen-Yong LiDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
Sheng WangDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
Yuan-Yuan GuoDepartment of Urology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.
First Affiliated Hospital of Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer is one of the most common types of cancer. Most gene mutations related to bladder cancer are dominantly acquired gene mutations and are not inherited. Previous comparative transcriptome analysis of urinary bladder cancer and control samples has revealed a set of genes that may play a role in tumor progression. Here we set out to investigate further the expression of two candidate genes, centromere protein U (CENPU) and mitochondrial ribosomal protein s28 (MRPS28) to better understand their role in bladder cancer pathogenesis. Our results confirmed that CENPU is up-regulated in human bladder cancer tissues at mRNA and protein levels. Gain-of-function and loss-of-function studies in T24 human urinary bladder cancer cell line revealed a hierarchical relationship between CENPU and MRPS28 in the regulation of cell viability, migration and invasion activity. CENPU expression was also up-regulated in

Indexed as

Bladder cancerCellCentromereProtein

Identifiers

PMID33602882
PMCPMC7893492
OpenAlexW3131588672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.